Stonepine Capital Management as of June 30, 2021
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 26 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Plc - Spnr Sponsored Ads | 17.7 | $34M | 2.8M | 12.13 | |
| Chiasma | 16.7 | $32M | 6.8M | 4.73 | |
| Cti Biopharma | 10.0 | $19M | 7.6M | 2.50 | |
| Adamas Pharmaceuticals | 7.4 | $14M | 2.7M | 5.28 | |
| Catalyst Biosciences Com New | 7.0 | $13M | 3.1M | 4.33 | |
| Strongbridge Biopharma Shs Usd | 5.1 | $9.8M | 3.3M | 2.97 | |
| Ovid Therapeutics (OVID) | 4.1 | $7.8M | 2.0M | 3.91 | |
| Conformis | 4.0 | $7.6M | 6.6M | 1.15 | |
| Affimed Therapeutics B V | 3.8 | $7.2M | 850k | 8.50 | |
| Apollo Endosurgery | 3.2 | $6.2M | 762k | 8.10 | |
| Xoma Corp Com New (XOMA) | 2.9 | $5.6M | 165k | 34.00 | |
| Celcuity (CELC) | 2.7 | $5.3M | 219k | 24.00 | |
| Yumanity Therapeutics | 2.7 | $5.1M | 442k | 11.65 | |
| Kalvista Pharmaceuticals (KALV) | 2.5 | $4.8M | 200k | 23.96 | |
| Iveric Bio | 1.7 | $3.3M | 517k | 6.31 | |
| Angion Biomedica Corp | 1.5 | $2.9M | 223k | 13.02 | |
| Gamida Cell SHS | 1.5 | $2.8M | 444k | 6.41 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.4 | $2.7M | 304k | 8.99 | |
| Exagen (XGN) | 1.3 | $2.5M | 170k | 14.99 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.3 | $2.4M | 1.2M | 2.02 | |
| Diamedica Therapeutics Com New (DMAC) | 1.0 | $1.9M | 420k | 4.45 | |
| Contrafect Corp Com New | 0.2 | $296k | 67k | 4.40 | |
| Neubase Therapeutics Ord | 0.1 | $149k | 31k | 4.80 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $125k | 47k | 2.67 | |
| Applied Genetic Technol Corp C | 0.0 | $4.0k | 1.0k | 4.00 | |
| Scynexis Com New (SCYX) | 0.0 | $1.0k | 100.00 | 10.00 |
